Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Gastrointestinal 1

Conditions

Lung Neoplasms 2Colorectal Neoplasms 2Breast Neoplasms 2Stomach Neoplasms 1Sleep Initiation and Maintenance Disorders 1Sedentary Behavior 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Lymphoma 1Liver Neoplasms 1Invasive Breast Carcinoma 1High-Frequency Microsatellite Instability 1Head and Neck Carcinoma 1Fatigue 1Fallopian Tube Neoplasms 1Carcinoma, Hepatocellular 1Breast Carcinoma In Situ 1

Interventions

Trastuzumab 350Paclitaxel 334Cyclophosphamide 315Docetaxel 291Capecitabine 181Doxorubicin 180Letrozole 166Tamoxifen 145Bevacizumab 124Fulvestrant 118Carboplatin 118exemestane 111Lapatinib 111Anastrozole 111Radiotherapy 105Epirubicin 104Gemcitabine 97palbociclib 84Exercise 78Vinorelbine 77Fluorouracil 77Surveys and Questionnaires 71pertuzumab 67Filgrastim 64Albumin-Bound Paclitaxel 64eribulin 55Magnetic Resonance Spectroscopy 55Everolimus 52Blood Specimen Collection 51Zoledronic Acid 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Breast Neoplasms × Monitoring, Physiologic × Clear all
NCT02699983 2021-04-13

eHealth Weight Loss Program in African American Breast Cancer Survivors

Rutgers, The State University of New Jersey

Phase NA Completed
35 enrolled 35 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms

NCT02677389 2019-11-18

Survivorship Care Plan in Promoting Physical Activity in Breast or Colorectal Cancer Survivors in Wisconsin

University of Wisconsin, Madison

Phase NA Completed
100 enrolled
BreastGastrointestinal

Breast Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡